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Invasive and skin community-associated (CA)–methi-
cillin-resistant  Staphylococcus aureus isolates from chil-
dren were matched with invasive CA–methicillin-sensitive
S. aureus strains during 2000–2004. Isolates were ana-
lyzed for presence of Panton-Valentine leukocidin. A
USA400 lineage clone (n = 6) and the predominant
USA300 lineage clone emerged.
C
ommunity-associated methicillin-resistant Staphylo-
coccus aureus (CA-MRSA) infections have been
increasing in children since the 1990s. Panton-Valentine
leukocidin (PVL) has been associated with CA-MRSA
strains (1–4).
As CA-MRSA infections have been increasing in pre-
viously healthy pediatric patients, we sought to do the fol-
lowing: 1) describe the clonal relatedness of these
CA-MRSAisolates by using pulsed-field gel electrophore-
sis (PFGE), 2) detect the presence of PVL genes among
CA-MRSA pediatric isolates causing invasive disease and
among isolates causing skin and soft tissue infections
(SSTI), 3) determine clinical and epidemiologic differ-
ences among patients with invasive disease caused by
community-associated methicillin-sensitive S. aureus
(CA-MSSA) versus those with disease caused by CA-
MRSA strains, 4) assess the geographic pattern of infec-
tion, and 5) measure the antimicrobial agent susceptibility
for CA-MRSA strains.
The institutional review board at Children’s Memorial
Hospital, a 253-bed, freestanding children’s hospital in
Chicago, Illinois, approved this study. A CA-MRSA strain
was defined as a clinical MRSA isolate recovered from a
pediatric patient (<1–18 years of age) who had no estab-
lished risk factors for MRSA infection (no residence in
long-term care facility, no hospitalization except for rou-
tine birth, and no permanent indwelling medical devices).
For most patients, strains were recovered within 72 hours
of admission. Exceptions included patients who had clini-
cal evidence of community-associated disease and whose
isolates were obtained after 72 hours of hospitalization.
Isolates recovered from normally sterile sites were defined
as invasive. We identified patients with S. aureus infec-
tions retrospectively by reviewing microbiology log books
from March 1, 2000, through November 30, 2004.
Demographic and clinical data retrieved included age,
sex, race, ZIP code of residence, length of hospitalization,
and clinical outcomes. When possible, patients with inva-
sive cases were matched to patients with CA-MRSA SSTI
and to those with invasive CA-MSSA infections by age
(within 12 months for those <18 months or within 3 years
for those >18 months), geographic location of patient res-
idence, or year of infection.
S. aureus isolates were identified by standard microbi-
ologic methods. For all S. aureus isolates that appeared
erythromycin resistant and clindamycin susceptible,
antibiotic double disk diffusion assay was performed (5).
Isolates of S. aureus, including control strain NCTC
8325 (Bio-Rad, Hercules, CA, USA), were analyzed by
PFGE after DNA digestion with SmaI. Resulting frag-
ments were separated by using the Staphylococcus pro-
gram 5 (GenePath System, Bio-Rad), and DNA banding
patterns were compared (6,7). PCR was used to detect the
PVL genes (8).
Categorical variables were analyzed by χ2 analysis.
Variables with non-normal distribution were analyzed by
Mann-Whitney U test; 2-tailed p value <0.05 was statisti-
cally significant (SPSS Inc., version 11.0, Chicago, IL,
USA).
From 166 MRSA patient strains noted in the microbi-
ology records, 21 patients with invasive CA-MRSA infec-
tion were identified. Three patient isolates were
unavailable and were excluded from analysis. Patients
with invasive CA-MRSA strains were case-matched with
patients with CA-MRSA SSTI (16/18 were matched by
age). During the study period, ≈31 cases of invasive CA-
MSSAdisease were identified and 10 cases were able to be
retrieved and matched with cases of invasive CA-MRSA
(9/10 case-patients were matched by age).
Groups with invasive CA-MRSA and groups with
invasive CA-MSSA did not differ significantly regarding
sex, initial leukocyte count, duration of fever, or length of
hospital stay. Pediatric patients with invasive CA-MRSA
infection were more likely to be African American (p =
0.01) and were febrile significantly longer than patients
with invasive CA-MSSA (p = 0.03). One of the patients
with invasive CA-MRSA died (Table 1).
Among the 18 patients with invasive CA-MRSA, 17
patients required surgical drainage, and 1 patient was
given extracorporeal membranous oxygenation. Among
the 10 patients with invasive CA-MSSA disease, all
required surgical intervention, but none died. Of 18
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for this group was 2.3 days. Seven children required no
hospitalization or hospitalization <24 hours.
Arepresentative PFGE result is depicted in the Figure.
Two predominant clones emerged among the local and
invasive CA-MRSAisolates. The clone A(n = 6) was iden-
tified to be of the USA400 lineage, and the B clone (n =
30) was identified to be of the USA300 lineage. No pre-
dominant clones emerged from the invasive MSSA iso-
lates; 6 unique clones were identified from 10 isolates
(data not shown). No isolates were of the USA300 or 400
lineage. The clinical manifestations of invasive disease in
patients with CA-MRSA disease from clone A were pneu-
monia with empyema, osteomyelitis, bacteremia, and sep-
tic arthritis. The clinical manifestations of invasive disease
in patients with clone B infection included sepsis, toxic-
shock syndrome, osteomyelitis, fasciitis, bacteremia,
pyomyositis, pneumonia with empyema, deep visceral
abscesses, and perirectal abscess with prostatitis; 1 patient
in this group died. Clone Awas found in a wide geograph-
ic distribution around metropolitan Chicago. In contrast,
clone B was located with more frequency within the city
limits of Chicago.
Antimicrobial susceptibility patterns among CA-
MRSA strains are detailed in Table 2. Two CA-MRSA iso-
lates that were positive by 3-D test belonged to the A0
clone. None of the MRSAisolates that caused SSTI was D-
test positive. The PVL gene was found in all of the CA-
MRSAisolates that caused invasive and SSTI disease but in
only 1 of 10 of the invasive CA-MSSA isolates (p<0.001).
Conclusions
PVL genes can be transmitted by means of bacterio-
phages, which allows them to be transmitted from 1 organ-
ism to another (9). When injected intradermally in rabbits,
PVL induces necrotic skin lesions (10), and PVL has been
described in S. aureus isolates from patients with necrotiz-
ing pneumonia, skin infections, and musculoskeletal infec-
tions. These outbreaks have been widespread
(1,2,8,11–13). We found a wide range of severity of infec-
tion caused by clonally related CA-MRSA, PVL-positive
isolates within our community, from superficial skin
abscesses to fatal disease.
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molecular typing methods, such as multilocus sequence
typing (MLST), which characterizes S. aureus species by
using sequences of 7 conserved housekeeping genes (7). In
accordance with other published studies in the United
States, the USA300 strain was the most frequently isolated
among CA-MRSA disease (12) in contrast to the invasive
CA-MSSA disease, which had no predominant clonality.
We also detected isolates of the USA400 lineage that har-
bored PVL genes. This lineage was previously described
as a cause of severe and fatal CA-MRSA disease in chil-
dren in the Midwest (14). Previous reports from University
of Chicago have described a cluster of 4 cases in which
USA400 isolates caused empyema and sepsis syndrome
with some features of toxic-shock syndrome (4); 3 children
died with necrotizing pneumonia and Waterhouse-
Friderichsen syndrome due to a PVL-positive, MLST-
identified type 1 strain (15). In contrast, our patient with
fatal toxic-shock syndrome did not have any primary pul-
monary pathology and had disease caused by a USA300
lineage strain.
Limitations to our study include its retrospective
nature and the limited numbers of patients. The geograph-
ic distribution of CA-MRSA isolates within the city likely
reflects the geographic distribution of our patient popula-
tion. Future prospective studies may further elucidate pos-
sible epidemiologic risk factors associated with acquiring
CA-MRSA invasive infection.
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